Package 10956-846-50

{"route": ["ORAL"], "spl_id": "05d6a014-cf43-4f17-afd9-014267e1d9ff", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0023513587646"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1147685"], "spl_set_id": ["6046dc50-f162-4e2d-aa3c-7d27efad477d"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Reese Pharmaceutical Co"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (10956-846-30)  / 30 TABLET in 1 BOTTLE", "package_ndc": "10956-846-30", "marketing_start_date": "20210415"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (10956-846-50)  / 50 TABLET in 1 BOTTLE", "package_ndc": "10956-846-50", "marketing_start_date": "20210415"}], "brand_name": "Refenesen Mucus Relief DM", "product_id": "10956-846_05d6a014-cf43-4f17-afd9-014267e1d9ff", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "10956-846", "generic_name": "Dextromethorphan Hydrobromide / Guaifenesin", "labeler_name": "Reese Pharmaceutical Co", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Refenesen Mucus Relief", "brand_name_suffix": "DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/1"}, {"name": "GUAIFENESIN", "strength": "400 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210415", "listing_expiration_date": "20261231"}